(1) The Director-General must, by notice in the Gazette, set out the process by which an independent review panel is to be established to review whether, in developing an import health standard, there has been sufficient regard to the scientific evidence about which a person consulted under section 22(6) has raised a significant concern.
(2) The notice required by subsection (1) must cover the following matters:
(a) the criteria for setting up an independent review panel; and
(b) how the Director-General will appoint an independent review panel, including the knowledge and experience required for appointees; and
(c) the procedures to be followed by—
(i) a person eligible to seek a review under subsection (1); and
(ii) an independent review panel, in undertaking its review; and
(d) the reporting requirements for an independent review panel.
(3) The Director-General must receive any report from an independent review panel and, as soon as is reasonably practicable, determine the issue in dispute after taking into account the findings and recommendations of the independent review panel, giving reasons for that determination.
(4) The Director-General must issue a notice under subsection (1) not later than 1 July 2008.
Section 22A: inserted, on 9 April 2008, by section 6 of the Biosecurity Amendment Act (No 2) 2008 (2008 No 21).